Medical Oncologist
Clinical Trials & Access Programs
Clinical Trial Eligibility: — Why Patients Are Turned Down
Being turned down from a clinical trial is frightening — it can feel like a door closing. Most rejections happen for specific medical reasons, not because you are too ill or not worth treating. Understanding which criterion you did not meet is the first step to knowing what comes next.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Rejection is usually medical, not arbitrary — Eligibility criteria exist to protect you and ensure the trial produces reliable results — not to exclude people randomly.
- Placebos are almost never given alone — In cancer trials you almost always receive standard care alongside either the experimental drug or a placebo.
- The experimental drug itself is free — The sponsor covers the cost of the trial treatment. Ask the coordinator exactly what other costs to expect before you enrol.
- One rejection does not close all doors — Different trials have different criteria. Not qualifying for one does not mean you are excluded from all of them.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Clinical trial eligibility criteria are written to make sure the trial is safe for you and its results are scientifically valid. Most rejections happen for medical reasons — your organ function, your current treatments, or where the cancer has spread. Being turned down from one trial does not mean you are out of options.
What does each eligibility criterion check?
| Eligibility factor | Usually meets criteria | Often does not meet criteria — ask your team |
|---|---|---|
| Your general fitness (performance status) | Able to carry out most daily activities without help | Confined to bed for the majority of the day |
| Liver, kidney and blood count readings | Results within the range the trial protocol specifies | Significant impairment — visible in your recent blood tests |
| Number of previous treatment lines | Falls within what the protocol allows | More prior treatments than the trial permits |
| Other health conditions | Stable and well controlled | Active autoimmune disease, recent serious cardiac event, or active infection |
| Whether cancer has spread to the brain | Some trials now specifically include brain metastases | Many trials still exclude them — but this is changing, so ask |
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
Will you receive a placebo, and will you have to pay?
The fear of receiving a placebo — and getting nothing real — is one of the most common reasons families hesitate to consider a trial. In cancer trials, a pure placebo arm almost never exists. You almost always receive the current standard treatment alongside either the experimental drug or a placebo add-on. The worst outcome in most trial designs is that you receive the care you would have received anyway.
Some trials are open-label, meaning everyone knows which treatment they are receiving. Ask your team to describe the specific arms in any trial they recommend before you decide.
On cost: the experimental drug is provided at no charge by the trial sponsor. What you may still pay for is travel to the trial centre for additional visits, investigations that fall outside the trial protocol, and routine supportive care the trial does not fund. Ask the trial coordinator for a written summary of what is and is not covered. You are entitled to that information before you sign.
What to do if you are turned down from a trial
Ask which criterion ruled you out
Your oncologist or trial coordinator should name the specific factor. A vague answer is not enough — you need to know whether it is something that could change.
Ask what other trials are open
Different trials for the same cancer type have different protocols and different inclusion criteria. Being excluded from one does not mean all options are closed.
Ask about compassionate use or named patient access
Some companies make an experimental drug available outside a trial while approval is pending. Your oncologist can approach the company on your behalf.
Check whether your eligibility could change
If organ function or performance status was the reason, ask whether better supportive care or time could bring you within range. Some exclusions are fixed; others are not.
Consider a second opinion at a high-volume centre
Oncologists who treat a large number of patients with your cancer type are more likely to know about open trials your current team may not be running.
Explore 52 more Cost, Access, Trials & Choosing a Hospital topics
Clinical Trials & Access Programs
- Basket and Umbrella Trials: The New Way Trials Are Designed
- Eligibility Criteria: Why Patients Get Rejected From Trials
- How to Find Cancer Clinical Trials in India
- Phase 1, 2 and 3 Trials: What the Numbers Mean for You
- Risks, Consent and Your Right to Withdraw
- What Happens After a Trial Ends?
- What Is a Clinical Trial and Should You Join One?
- Who Pays for Treatment in a Clinical Trial?
- Will I Get a Placebo Instead of Real Treatment?
Cost, Insurance & Access in India
- Are Generic Targeted Therapy Drugs Safe and Effective?
- Biosimilars for Trastuzumab, Bevacizumab and Rituximab in India
- CGHS, ECHS, ESI and State Schemes for Cancer Drugs
- Can You Get Targeted Therapy in a Government Hospital?
- Compassionate Access and Expanded Access Programs Explained
- Cost of NGS Testing vs the Cost of Treating Blindly
- Cost of Targeted Therapy in India: Monthly Price Guide by Drug Class
- Does Ayushman Bharat Cover Targeted Therapy?
- Hidden Costs Nobody Warns You About in Cancer Treatment
- How to File a Cancer Treatment Insurance Claim Without Rejection
- How to Talk to Your Doctor About Affording Treatment
- Importing a Cancer Drug Not Available in India
- NGOs and Crowdfunding for Cancer Treatment in India
- Patient Assistance Programs for Targeted Therapy Drugs in India
- Section 80DDB and Tax Deductions for Cancer Treatment
- Total Cost of Care: Targeted Therapy vs Chemotherapy Compared
- What Happens If You Have to Stop Treatment Because of Cost?
- Will Health Insurance Pay for Oral Cancer Tablets Taken at Home?
Hospital Choice, Second Opinion & Decision Pages
- A Guide for International and NRI Patients Seeking Cancer Care in India
- Day Care Infusion Centres: What to Expect on Infusion Day
- Documents to Bring to Your First Oncology Consultation
- Follow-Up on Oral Targeted Therapy: In Person or Teleconsult?
- Getting a Second Opinion on Your Targeted Therapy Plan
- How a Molecular Tumour Board Reviews Your Case
- How to Choose a Hospital for Targeted Therapy in India
- Medical Oncologist vs Precision Oncology Specialist: Who Do You Need?
- Online and Teleconsultation Second Opinions: How They Work
- Red Flags: Signs Your Cancer Care May Not Be Up to Standard
- Transferring Your Care to Another Hospital Mid-Treatment
- What a Good Second Opinion Actually Checks: A 10-Point Audit
- What a Precision Oncology Program Should Include: A Checklist
- What to Ask Before Committing to a Cancer Treatment Plan
Work, Travel, Legal & Insurance Rights
- Buying Life or Health Insurance After a Cancer Diagnosis
- Can You Keep Working Full Time on Targeted Therapy?
- Disability Certificate for Cancer Patients in India: How to Apply
- Flying With Cancer: Fitness to Fly and Airline Rules
- Making a Will and Organising Documents During Serious Illness
- Managing Fatigue and Meetings: Practical Workday Strategies
- Planning a Holiday Around Your Treatment Schedule
- Returning to Work After a Treatment Break
- Should You Tell Your Employer About Your Cancer Diagnosis?
- Sick Leave and Employment Rights for Cancer Patients in India
- Travel Insurance When You Have Cancer
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Why was I turned down from a clinical trial?
The most common reasons are organ function readings outside the range the protocol requires, more prior treatments than the trial allows, a performance status below the minimum, or a health condition the protocol excludes. You are entitled to know which criterion applied. Ask your oncologist or the trial coordinator to name the specific reason — a general answer is not enough to help you understand your options or whether your situation could change.
Will I get a placebo and miss out on real treatment?
In cancer trials, a pure placebo arm almost never exists. The standard design places the experimental drug or a placebo on top of the treatment you would receive anyway. That means the worst outcome in most trials is that you receive the current standard of care — not nothing. Before you consent, ask your team to describe the exact arms and what each one receives. If a pure placebo arm exists in a trial being proposed, it will be stated plainly in the consent document.
How much does joining a clinical trial cost?
The experimental drug is covered by the trial sponsor — you do not pay for it. What can still cost you is travel to the trial centre for extra visits, investigations outside the trial protocol, and routine supportive care the trial does not fund. Before you enrol, ask for a written breakdown of what the trial covers and what it does not. Some academic trials have provisions to help with travel costs; it is reasonable to ask.
What is performance status and why does it affect eligibility?
Performance status is a standardised measure of how well you can carry out daily activities. Oncologists use the ECOG scale, where 0 means fully active and 4 means completely confined to bed. Most trials require a score of 0 or 1, and some allow 2. It matters because patients with very low performance status are at higher risk of serious side effects, and including them makes trial results harder to interpret. If this is why you were excluded, ask whether better supportive care might improve your score enough to qualify.
Can I appeal if I do not meet the eligibility criteria?
Formal appeals are rarely possible because eligibility criteria are written into the trial protocol and apply equally to everyone. What is possible is asking whether other open trials have different criteria, whether a compassionate use or named patient access programme exists for the drug, and whether your eligibility should be checked again if your situation changes. A second opinion from an oncologist at a centre that runs a high volume of your cancer type can sometimes identify a trial your current team was not aware of.